Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes

Cancer Epidemiology

Volumn 35, Issue 4, 2011, Pages

  Kawankar, Nikesh ^a   Jijina, Farah ^b   Ghosh, Kanjaksha ^a   Vundinti, Babu Rao ^a  

^a NATIONAL INSTITUTE OF IMMUNOHAEMATOLOGY   (India)

^b KEM HOSPITAL   (India)

Author keywords

Chromosome aberrations; Comparative genomic hybridization; DNA copy number changes; Myelodysplastic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 21; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 7; CHROMOSOME 9; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; HUMAN; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INDIA; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; YOUNG ADULT;

EID: 79960567835     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2010.11.009     Document Type: Article

References (24)

1. Greenberg P.L. The smoldering myeloid leukemic states. Clinical and biologic features. Blood 1983, 61:1035-1044. [Review].
2. Levine E.G., Bloomfield C.D. Leukemias and myelodysplastic syndromes secondary to drug, radiation and environmental exposure. Semin Oncol 1992, 19:47-84. [Review].
3. Rowley J.D. Cytogenetic analysis in leukemia and lymphoma. An introduction. Semin Hematol 2000, 37:315-319.
4. Michels S.D., Mckenna R.W., Arthur D.C., Brunning R.D. Therapy related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 1985, 65:1364-1372.
5. Lai J.L., Preudhomme C., Zandecki M., Flactif M., Vanrumbeke M., Lepelley P., et al. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterised by specific dysgranulopoiesis and high incidence of p53 mutation. Leukemia 1995, 9:370-381.
6. Pinkel D., Strauma T., Gray J.W. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1998, 83:2934-2938.
7. Castuma M.V., Rao P.H., Acevedo S.H., Larripa I. Comparative genomic hybridization study of de novo myeloid neoplasia. Acta Hematol 2000, 104:25-30.
8. Kim M.H., Stewart J., Devlin C., Kim Y.T., Boyd E., Connor M. The application of comparative genomic hybridization as an additional tool in the chromosome analysis of acute myeloid leukemia and myelodysplastic syndromes. Cancer Genet Cytogenet 2001, 126:26-33.
9. Wilkens L., Burkhardt D., Tchinda J., Busche G., Werner M., Nolte M., et al. Cytogenetic aberrations in myelodysplastic syndrome detected by Comparative genomic hybridization and fluorescence in situ hybridization. Diagn Mol Pathol 1999, 8(1):47-53.
10. Wang X.Q., Ryder J., Gross S.A., Lin G., Irons R.D. Prospective analysis of clinical and cytogenetic features of 435 cases of MDS diagnosed using the WHO (2001) classification: a prognostic scoring system for predicting survival in RCMD. Int J Hematol 2009, 890:361-369.
11. Haase D., Germing U., Schanz J., Pfeilstocker M., Nosslinger T., Hildebrandt B., et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007, 110:4385-4395.
12. Vundinti B.R., Kerketta L., Jijina F., Ghosh K. Cytogenetic study of myelodysplasic syndrome from India. Indian J Med Res 2009, 130(August):155-159.
13. Williamson P.J., Kruger A.R., Reynolds P.J. Establishing the incidence of myelodysplastic syndrome. Br J Haematol 1994, 87:743-745.
14. Panani A.D. Cytogenetic findings in adult greek myelodysplastic syndrome patients: predominance of single trisomy 8. In Vivo 2006, 20:115-118.
15. Chen Z., Pasquini M., Hong B., Heikens M., Tsai S. The human penumbra gene is mapped to a region on chromosome 7 frequently deleted in myeloid malignancies. Cancer Genet Cytogenet 2005, 162:95-98.
16. Liang H., Fairman J., Claxton D.F., Nowell P.C., Green E.D., Nagarajan L. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci. Proc Natl Acad Sci USA 1998, 3781-3785.
17. Le Beau M.M., Espinosa R., Davis E.M., Eisenbartt J.D., Larson R.A., Green E.D. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 1996, 88:1930-1935.
18. Chen B., Zhao W.L., Jin J., Xue Y.Q., Cheng X., Chen X.T., et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 2005, 19(5):767-775.
19. Solinas-Toldo S., Lampel S., Stilgenbauer S., Nickolenko J., Benner A., Dohner H., et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997, 20:399-407.
20. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998, 20:207-211.
21. Pollack J.R., Perou C.M., Alizadeh A.A., Eisen M.B., Pergamenschikov A., Williams C.F., et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999, 23:41-46.
22. Suela J., Alvarez S., Cigudosa J.C. DNA profiling by arrayCGH in acute myeloid leukemia and myelodysplastic syndromes. Cytogenet Genome Res 2007, 118:304-309.
23. Starczynowski D.T., Vercauteren S., Telenius A., Sung S., Tohyama K., Brooks-Wilson A., et al. High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival. Blood 2008, 112:3412-3424.
24. Praulich I., Tauscher M., Gohring G., Glaser S., Hofmann W., Feurstein S. et al. Clonal heterogeneity in childhood myelodysplastic syndromes - challenge for the detection of chromosomal imbalances by array-CGH. Genes Chromosomes Cancer 2010, 49:885-900.